This review highlights the potential of gene therapy targeting cellular and mitochondrial mechanisms for the treatment of ventricular arrhythmias.
Answers are grounded in this paper and cite their sources.
Gene therapy targets for ventricular arrhythmias merit further study; leaves clinical translation open pending prospective trials.
-handling in the development of congenital as well as acquired ventricular arrhythmia syndromes. We highlight the therapeutic potential of gene therapy as a novel and innovative approach for future arrhythmia therapy. Furthermore, we discuss various promising cellular and mitochondrial targets for therapeutic gene transfer currently under investigation.
No takes yet. Share an insight, caveat, or question.
Paar et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: